NM21-1480

· Numab Therapeutics AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NM21-1480, covering 2025-05-23 to 2025-05-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]